Manipulating the Immune System with Immune Globulin
- 9 January 1992
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 326 (2) , 107-116
- https://doi.org/10.1056/nejm199201093260206
Abstract
ALMOST as soon as a therapeutically useful concentrated immune globulin product became available for intramuscular use, it was obvious that a preparation that could be administered intravenously would be advantageous.1 , 2 However, many years of immunochemical research were required before a concentrated, biologically active, and safe preparation of immune globulin suitable for intravenous use became available. In the past decade, chemists have learned how to prevent protein aggregation while concentrating immune globulin. Purification can be achieved by chromatography, and stabilization of the intact immune globulin is then promoted by acidification with pepsin or the addition of sugars, amino acids, or both. . . .Keywords
This publication has 95 references indexed in Scilit:
- Thrombotic Thrombocytopenic Purpura: Report of a Case with a Possible Response to High-Dose Intravenous Gamma GlobulinActa Haematologica, 1989
- Intravenous treatment with γ-globulin of autoimmune neutropenia of infancyThe Journal of Pediatrics, 1988
- High-dose IVIgG in autoimmune hemolytic anemiaThe Journal of Pediatrics, 1986
- Treatment of Refractory Immune Thrombocytopenic Purpura with an Anti-Fcγ-Receptor AntibodyNew England Journal of Medicine, 1986
- Post‐transfusion purpura responding to high dose intravenous IgG: further observations on pathogenesisBritish Journal of Haematology, 1985
- High-dose intravenous intact IgG infusion in refractory autoimmune hemolytic anemia (Evans syndrome)The Journal of Pediatrics, 1985
- Identification by HLA Typing of Intrauterine-Derived Maternal T Cells in Four Patients with Severe Combined ImmunodeficiencyNew England Journal of Medicine, 1982
- Transient Reversal of Thrombocytopenia in Idiopathic Thrombocytopenic Purpura by High-Dose Intravenous Gamma GlobulinNew England Journal of Medicine, 1982
- Splenectomy in the Management of the Thrombocytopenia of the Wiskott–Aldrich SyndromeNew England Journal of Medicine, 1980
- Preparation and Properties of Serum and Plasma Proteins. IV. A System for the Separation into Fractions of the Protein and Lipoprotein Components of Biological Tissues and Fluids1a,b,c,dJournal of the American Chemical Society, 1946